• Biohaven (NYSE: BHVN) shifts CSO to innovation role, promotes discovery head Stock Titan Thu, 09 Jul 2026 21:11:56 GMT
• what's going on with biohaven stock monday? - biohaven (nyse:bhvn) Benzinga Mon, 29 Jun 2026 18:04:13 GMT
• Biohaven (BHVN) Shares Decline Nearly 10% Amid Market Fluctuatio GuruFocus Mon, 29 Jun 2026 14:46:05 GMT
• bofa downgrades biohaven stock on epilepsy drug concerns Investing.com Mon, 29 Jun 2026 11:30:42 GMT
• bofa securities downgrades biohaven pharma (bhvn) to underperform StreetInsider Mon, 29 Jun 2026 10:14:37 GMT
• Biohaven looks to obesity to bounce back from run of clinical and regulatory failures BioSpace Mon, 01 Jun 2026 07:00:00 GMT
• biohaven reports first-in-human dosing of oral pkm2 modulator, bhv-8100, targeting metabolic restoration and immunomodulation PR Newswire Mon, 01 Jun 2026 07:00:00 GMT
• raymond james reiterates strong buy on biohaven stock after positive drug trial data Investing.com Australia Wed, 27 May 2026 15:25:36 GMT
• biohaven reports positive clinical biomarker and patient data: first mode and trap extracellular protein degraders achieve deep, r... PR Newswire Wed, 27 May 2026 11:30:00 GMT
• biohaven reports new clinical data in epilepsy with opakalim, a selective kv7.2/7.3 activator, highlighting seizure control and ma... PR Newswire Tue, 26 May 2026 11:30:00 GMT
• Epilepsy drug opakalim shows seizure control with low side-effect rates Stock Titan Tue, 26 May 2026 07:00:00 GMT
• neomorph appoints biopharma leader robert j. hugin as chairman of the board GlobeNewswire Wed, 13 May 2026 07:00:00 GMT
• biohaven pharmaceutical holding co receives investment bank analyst rating update by investing.com Investing.com India Wed, 13 May 2026 07:00:00 GMT
• h.c. wainwright reiterates biohaven stock rating ahead of trial Investing.com Tue, 12 May 2026 07:00:00 GMT
• biohaven ltd. (nyse: bhvn) files shelf to register shares, debt and warrants Stock Titan Mon, 04 May 2026 20:23:51 GMT
• biohaven reports recent business developments and first quarter 2026 financial results PR Newswire Mon, 04 May 2026 07:00:00 GMT
• obesity drugmakers chase weight loss. biohaven is betting on muscles. Pharma Voice Wed, 29 Apr 2026 07:00:00 GMT
• why biohaven (bhvn) is up 10.6% after bullish analyst coverage of late-stage pipeline prospects simplywall.st Thu, 16 Apr 2026 07:00:00 GMT
• biohaven’s bhv-1450 shows promise for pemphigus vulgaris BioWorld News Mon, 13 Apr 2026 07:00:00 GMT
• biohaven stock price target lowered to $10 by h.c. wainwright Investing.com Fri, 03 Apr 2026 07:00:00 GMT
• biohaven ltd. (bhvn) stock price, news, quote and history Yahoo Finance UK Thu, 02 Apr 2026 11:12:24 GMT
• biohaven jumps 10.9% amid robust intraday rally—what’s driving this upswing? Bitget Wed, 01 Apr 2026 07:00:00 GMT
• biohaven advances obesity drug aimed at fat loss without muscle loss Stock Titan Thu, 19 Mar 2026 07:00:00 GMT
• biohaven's phase 2 obesity study with taldefgrobep alfa, a novel myostatin-activin pathway inhibitor, completes enrollment PR Newswire Thu, 19 Mar 2026 07:00:00 GMT
• biohaven therapeutics discloses prodrugs of betahistine BioWorld News Thu, 19 Mar 2026 07:00:00 GMT
• biohaven (nyse: bhvn) outlines r&d pipeline and 2026 shareholder votes Stock Titan Fri, 13 Mar 2026 07:00:00 GMT
• republican senator slams fda rare disease rebuffs, pledges to investigate recent actions: bloomberg Fierce Biotech Tue, 10 Mar 2026 07:00:00 GMT
• ‘bureaucratic idiocy’: gop senator to investigate fda rejections Fierce Biotech Tue, 10 Mar 2026 07:00:00 GMT
• raymond james reiterates strong buy on biohaven stock after competitor data Investing.com Mon, 09 Mar 2026 07:00:00 GMT
• what's going on with biohaven stock on monday? - biohaven (nyse:bhvn) Benzinga Mon, 09 Mar 2026 07:00:00 GMT
• biohaven stock price target lowered to $10 by h.c. wainwright Investing.com Wed, 04 Mar 2026 08:00:00 GMT
• biohaven pharmaceutical holding co receives investment bank analyst rating update by investing.com Investing.com Australia Wed, 04 Mar 2026 08:00:00 GMT
• biohaven pharma (bhvn) pt raised to $23 at rbc capital StreetInsider Tue, 03 Mar 2026 14:01:35 GMT
• RBC Capital raises Biohaven Pharma stock price target on model tweaks Investing.com Tue, 03 Mar 2026 08:00:00 GMT
• Biohaven reduces scope of R&D cutbacks as pipeline progresses Fierce Biotech Tue, 03 Mar 2026 08:00:00 GMT
• leerink partners reiterates biohaven pharma stock outperform rating Investing.com Tue, 03 Mar 2026 08:00:00 GMT
• piper sandler reiterates biohaven stock rating on 2026 catalysts Investing.com Tue, 03 Mar 2026 08:00:00 GMT
• biohaven reduces scope of r&d cuts as pipeline progresses Fierce Biotech Tue, 03 Mar 2026 08:00:00 GMT
• biohaven reports recent business developments and fourth quarter and full year 2025 financial results PR Newswire Mon, 02 Mar 2026 08:00:00 GMT
• obsessive compulsive disorder market: high-growth opportunities for investors to 2034 – delveinsight | biohaven pharma, abbvie, bi... StreetInsider Thu, 26 Feb 2026 14:31:12 GMT
• Biohaven says FDA roadblocks leave rare disease patients in limbo Pharma Voice Thu, 26 Feb 2026 08:00:00 GMT
• analysts are bullish on top healthcare stocks: biohaven ltd. (bhvn), oric pharmaceuticals (oric) The Globe and Mail Tue, 24 Feb 2026 08:00:00 GMT
• piper sandler reiterates biohaven stock rating on epilepsy trial Investing.com Mon, 23 Feb 2026 08:00:00 GMT
• Biohaven charts comeback path after FDA blow, placing bets on obesity Fierce Biotech Fri, 20 Feb 2026 08:00:00 GMT
• analysts conflicted on these healthcare names: biohaven ltd. (bhvn), olema pharmaceuticals (olma) and hims & hers health (hims) The Globe and Mail Fri, 20 Feb 2026 08:00:00 GMT
• a pill explores new frontier in early parkinson’s disease treatment UConn Today Wed, 18 Feb 2026 08:00:00 GMT
• 'It's really a dire time for patients': Biohaven CEO says FDA red tape is blocking access to rare disease treatments Fierce Biotech Fri, 13 Feb 2026 08:00:00 GMT
• uconn participating in novel clinical trial for curbing the most common type of kidney inflammation UConn Today Mon, 09 Feb 2026 08:00:00 GMT
• goldman sachs initiates coverage on biohaven pharma stock with buy rating Investing.com Fri, 06 Feb 2026 08:00:00 GMT
• rbc capital upgrades biohaven pharma (bhvn) to outperform StreetInsider Wed, 21 Jan 2026 10:05:43 GMT
• biohaven stock rating upgraded by rbc capital on promising cns data Investing.com Wed, 21 Jan 2026 08:00:00 GMT
• biohaven (bhvn) is up 15.6% after showcasing mode and trap degrader data in autoimmune diseases simplywall.st Wed, 21 Jan 2026 08:00:00 GMT
• JPM26: After a Tough 2025, Biohaven Is Gearing Up To Challenge Goliath—Lilly BioSpace Tue, 20 Jan 2026 08:00:00 GMT
• Biohaven Highlights Portfolio Progress, Positive Early Patient Data from Priority Degrader Programs and Anticipated Milestones at ... PR Newswire Mon, 12 Jan 2026 08:00:00 GMT
• biohaven stock maintains outperform rating at baird on promising igan data Investing.com UK Mon, 12 Jan 2026 08:00:00 GMT
• biohaven to present at the 44th annual j.p. morgan healthcare conference on january 12, 2026 PR Newswire Mon, 12 Jan 2026 08:00:00 GMT
• chinese biotechs strike a record us$136 billion in out-licensing deals in 2025 South China Morning Post Thu, 08 Jan 2026 08:00:00 GMT
• Biohaven flunks phase 2 depression trial, adding to concerns for pivotal epilepsy readout Fierce Biotech Fri, 02 Jan 2026 08:00:00 GMT
• Biohaven Notches Another Psychiatric Failure Months After Key FDA Rejection BioSpace Fri, 02 Jan 2026 08:00:00 GMT
• biohaven pharmaceuticals faces setback as bhv-7000 fails in major depressive disorder trials geneonline.com Fri, 02 Jan 2026 08:00:00 GMT
• stifel reiterates buy rating on xenon pharmaceuticals stock amid competitor setback by investing.com Investing.com Nigeria Fri, 26 Dec 2025 14:36:37 GMT
• Biohaven’s ion channel drug fails again, this time in major depressive disorder Endpoints News Fri, 26 Dec 2025 08:00:00 GMT
• h.c. wainwright maintains biohaven stock at neutral after mdd trial failure Investing.com Fri, 26 Dec 2025 08:00:00 GMT
• biohaven’s phase ii depression trial falls short, but analysts downplay impact – wall street looks ahead to epilepsy data Stocktwits Fri, 26 Dec 2025 08:00:00 GMT
• biohaven’s phase ii depression trial falls short, but analysts downplay impact – wall street looks ahead to epilepsy data Stocktwits Thu, 25 Dec 2025 01:15:02 GMT
• biohaven’s phase ii depression trial falls short, but analysts downplay impact – wall street looks ahead to epilepsy data Stocktwits Wed, 24 Dec 2025 19:15:02 GMT
• Biohaven Provides Update From Phase 2 Proof-of-Concept Study with BHV-7000 in Major Depressive Disorder PR Newswire Wed, 24 Dec 2025 08:00:00 GMT
• biohaven stock falls after depression drug misses primary endpoint Investing.com Wed, 24 Dec 2025 08:00:00 GMT
• biohaven’s depression drug misses primary endpoint in phase 2 study Investing.com Wed, 24 Dec 2025 08:00:00 GMT
• stock watch: what biohaven can teach us about optimism and reality Citeline News & Insights Mon, 22 Dec 2025 08:00:00 GMT
• biohaven (bhvn) is down 5.9% after strong early bhv-1510 combo data - has the bull case changed? simplywall.st Sun, 21 Dec 2025 08:00:00 GMT
• biohaven jumps on early-stage data for antibody drug conjugate combo MSN Fri, 12 Dec 2025 14:45:11 GMT
• Biohaven Presents Clinical Safety and Efficacy Data for BHV-1510, a Next-Generation Trop2 Antibody Drug Conjugate in Combination w... PR Newswire Thu, 11 Dec 2025 08:00:00 GMT
• biohaven reports promising results for cancer drug bhv-1510 Investing.com Thu, 11 Dec 2025 08:00:00 GMT
• biohaven stock jumps after promising cancer drug results Investing.com Thu, 11 Dec 2025 08:00:00 GMT
• biohaven jumps on early-stage data for antibody drug conjugate combo Seeking Alpha Thu, 11 Dec 2025 08:00:00 GMT
• multiple system atrophy market to reach new heights in growth by 2034, delveinsight predicts | ionis pharma, biohaven pharma, lund... Barchart.com Mon, 08 Dec 2025 13:54:13 GMT
• obsessive compulsive disorder competitive landscape report 2025: 5+ companies and 5+ therapies pushing forward the next wave of tr... The Globe and Mail Fri, 28 Nov 2025 08:00:00 GMT
• ubs downgrades biohaven stock to neutral on pipeline setbacks Investing.com Wed, 26 Nov 2025 08:00:00 GMT
• jim cramer on biohaven: “the stock seems very low to me” Yahoo Finance Mon, 24 Nov 2025 08:00:00 GMT
• fda reversals send uniqure, biohaven, capricor, more into a ‘tailspin’ BioSpace Mon, 24 Nov 2025 08:00:00 GMT
• biohaven seeks $150 million from wall street following fda rejection BioSpace Wed, 12 Nov 2025 08:00:00 GMT
• biohaven (nyse: bhvn) prices 23,333,334-share public offering for $175m gross proceeds Stock Titan Wed, 12 Nov 2025 08:00:00 GMT
• biohaven announces pricing of $175 million public offering of common shares Sahm Wed, 12 Nov 2025 08:00:00 GMT
• Biohaven Reports Third Quarter 2025 Financial Results and Recent Business Developments PR Newswire Mon, 10 Nov 2025 08:00:00 GMT
• biohaven posts 3q loss, announces cost-cutting measures Hartford Business Journal Mon, 10 Nov 2025 08:00:00 GMT
• biohaven disappointed as rare disease therapy faces fda setback 'despite promising results' Indian Pharma Post Mon, 10 Nov 2025 08:00:00 GMT
• piper sandler lowers biohaven stock price target to $30 on fda rejection Investing.com Thu, 06 Nov 2025 08:00:00 GMT
• fda issues complete response letter to biohaven pharmaceuticals declining approval of spinocerebellar ataxia therapy geneonline.com Thu, 06 Nov 2025 08:00:00 GMT
• the fda is a mess, but that doesn't mean it should be blamed for everything statnews.com Thu, 06 Nov 2025 08:00:00 GMT
• biohaven pharmaceuticals to cut r&d spending by 60% after fda rejection of vyglxia for spinocerebellar ataxia geneonline.com Thu, 06 Nov 2025 07:29:55 GMT
• biohaven sinks as fda declines to approve lead drug; bofa downgrades Seeking Alpha Wed, 05 Nov 2025 17:34:00 GMT
• biohaven shares plunge after us fda declines to approve brain disorder drug Reuters Wed, 05 Nov 2025 15:02:29 GMT
• Knocked back by the FDA, Biohaven turns to major cost cuts BioPharma Dive Wed, 05 Nov 2025 08:00:00 GMT
• FDA rejects Biohaven approval request for troriluzole, triggering R&D cost cutting Fierce Biotech Wed, 05 Nov 2025 08:00:00 GMT
• FDA Issues Complete Response Letter for Spinocerebellar Ataxia Agent Troriluzole NeurologyLive Wed, 05 Nov 2025 08:00:00 GMT
• The Shocking Plot Twist That Sent This Biotech Crashing Investor's Business Daily Wed, 05 Nov 2025 08:00:00 GMT
• biohaven cuts r&d spending by 60% after fda rejection of drug for rare neurodegenerative disease BioSpace Wed, 05 Nov 2025 08:00:00 GMT
• fda turns down ataxia drug, prompting biohaven to cut r&d spend, realign pipeline FirstWord Pharma Wed, 05 Nov 2025 08:00:00 GMT
• biohaven pharmaceutical stock hits 52-week low at $8.38 Investing.com Wed, 05 Nov 2025 08:00:00 GMT
• dismay as fda declines to approve biohaven's ataxia drug pharmaphorum Wed, 05 Nov 2025 08:00:00 GMT
• fda rejects biohaven's ataxia drug, shutting down company's second attempt to win approval Endpoints News Wed, 05 Nov 2025 08:00:00 GMT
• biohaven stock hits 52-week low, cuts r&d spending after fda rejection - biohaven (nyse:bhvn) Benzinga Wed, 05 Nov 2025 08:00:00 GMT
• biohaven sinks as fda rejects lead drug (update) (bhvn:nyse) Seeking Alpha Wed, 05 Nov 2025 08:00:00 GMT
• biohaven stock drops as fda rejects sca treatment, company cuts r&d spend Investing.com Wed, 05 Nov 2025 08:00:00 GMT
• biohaven (bhvn) stock plunges on fda setback – will its biotech pipeline fuel a comeback? TechStock² Wed, 05 Nov 2025 08:00:00 GMT
• fda issues complete response letter for biohaven's vyglxia (troriluzole) new drug application for spinocerebellar ataxia PR Newswire Wed, 05 Nov 2025 01:06:00 GMT
• biohaven pharmaceutical holding company ltd. (bhvn) analyst insights, price targets and recommendations Yahoo Finance UK Tue, 04 Nov 2025 23:47:28 GMT
• FDA Issues Complete Response Letter for Biohaven's VYGLXIA (troriluzole) New Drug Application for Spinocerebellar Ataxia PR Newswire Tue, 04 Nov 2025 08:00:00 GMT
• biohaven stock plummets on fda concerns despite raymond james’ strong buy Investing.com Mon, 03 Nov 2025 08:00:00 GMT
• spinocerebellar ataxias clinical landscape, companies, therapeutic evaluation, therapies, treatment framework, and pipeline analys... Barchart.com Tue, 28 Oct 2025 07:00:00 GMT
• The limits of FDA flexibility are tested as a controversial Biohaven drug decision nears STAT Thu, 09 Oct 2025 07:00:00 GMT
• fda to decide on biohaven’s troriluzole for rare neurodegenerative disease amid efficacy concerns geneonline.com Thu, 09 Oct 2025 07:00:00 GMT
• should biohaven's (bhvn) accelerating cash burn and shorter runway require action from investors? Sahm Wed, 08 Oct 2025 07:00:00 GMT
• a look at biohaven (bhvn) valuation as cash runway narrows and funding concerns grow simplywall.st Mon, 06 Oct 2025 07:00:00 GMT
• obsessive compulsive disorder market dynamics indicate upward trajectory through 2034, reports delveinsight | biohaven pharma, abb... Barchart.com Mon, 29 Sep 2025 07:00:00 GMT
• obsessive compulsive disorder market dynamics indicate upward trajectory through 2034, reports delveinsight | biohaven pharma, abb... Barchart.com Fri, 26 Sep 2025 14:52:00 GMT
• biohaven ltd. (nyse: bhvn) long term investor alert: investigation of potential wrongdoing openPR.com Sat, 20 Sep 2025 07:00:00 GMT
• biohaven stock price target lowered to $26 at ubs on troriluzole timeline Investing.com UK Tue, 16 Sep 2025 07:00:00 GMT
• biohaven pharmaceuticals prepares for vyglxia launch pending fda approval for spinocerebellar ataxia treatment geneonline.com Mon, 08 Sep 2025 03:09:23 GMT
• biohaven pharmaceuticals prepares for vyglxia distribution pending fda approval for spinocerebellar ataxia treatment geneonline.com Sun, 07 Sep 2025 19:59:47 GMT
• biohaven pharmaceuticals announces immediate distribution of fda-approved spinocerebellar ataxia drug vyglxia geneonline.com Sun, 07 Sep 2025 14:14:30 GMT
• biohaven pharmaceuticals prepares for immediate distribution of vyglxia pending fda approval for spinocerebellar ataxia treatment geneonline.com Sun, 07 Sep 2025 01:07:35 GMT
• biohaven pharmaceuticals announces fda approval and immediate distribution of vyglxia for spinocerebellar ataxia treatment geneonline.com Sat, 06 Sep 2025 15:08:53 GMT
• biohaven pharmaceuticals prepares for vyglxia launch pending fda approval for spinocerebellar ataxia treatment geneonline.com Sat, 06 Sep 2025 12:02:27 GMT
• biohaven pharmaceuticals prepares for immediate distribution of vyglxia pending fda approval geneonline.com Sat, 06 Sep 2025 07:00:00 GMT
• in endpoints news , hannah england and matt byron discuss biopharmaceutical single-asset dealmaking structures Ropes & Gray LLP Wed, 03 Sep 2025 07:00:00 GMT
• biohaven’s rare disease drug is ‘ready to ship on day 1’ following fda approval BioPharma Dive Wed, 03 Sep 2025 07:00:00 GMT
Biohaven Pharmaceuticals(NYSE:BHVN) 
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological diseases and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as id developing Rimegepant for preventive t...
Website: http://www.biohavenpharma.com
Founded: 2013
Full Time Employees: 647
CEO: Vlad Coric
Sector: Healthcare
Industry: Biotechnology